Truncated structural variants of lipoarabinomannan in ethambutol drug-resistant strains of Mycobacterium smegmatis. Inhibition of arabinan biosynthesis by ethambutol.
about
Characterization of the DNA-binding domain and identification of the active site residue in the 'Gyr A' half of Leishmania donovani topoisomerase IIMycobacterial lipoarabinomannan: an extraordinary lipoheteroglycan with profound physiological effectsMolecular genetic analysis of nucleotide polymorphisms associated with ethambutol resistance in human isolates of Mycobacterium tuberculosisBiosynthesis of mycobacterial lipoarabinomannan: role of a branching mannosyltransferaseEmbA is an essential arabinosyltransferase in Mycobacterium tuberculosisVariation in mannose-capped terminal arabinan motifs of lipoarabinomannans from clinical isolates of Mycobacterium tuberculosis and Mycobacterium avium complex.Genetic basis for the synthesis of the immunomodulatory mannose caps of lipoarabinomannan in Mycobacterium tuberculosis.Sequencing of oligoarabinosyl units released from mycobacterial arabinogalactan by endogenous arabinanase: identification of distinctive and novel structural motifsNew insights into the biosynthesis of mycobacterial lipomannan arising from deletion of a conserved gene.Genetics and pulmonary medicine. 5. Genetics of drug resistant tuberculosisControlled expression of branch-forming mannosyltransferase is critical for mycobacterial lipoarabinomannan biosynthesisRole of embB codon 306 mutations in Mycobacterium tuberculosis revisited: a novel association with broad drug resistance and IS6110 clustering rather than ethambutol resistanceEmerging therapeutic targets in tuberculosis: post-genomic era.Development of a quantitative assay for mycobacterial endogenous arabinase and ensuing studies of arabinase levels and arabinan metabolism in Mycobacterium smegmatisA glycomic approach reveals a new mycobacterial polysaccharide.Antituberculosis thiophenes define a requirement for Pks13 in mycolic acid biosynthesisNovel mutations within the embB gene in ethambutol-susceptible clinical isolates of Mycobacterium tuberculosis.Mycobacterial cell wall biosynthesis: a multifaceted antibiotic target.Transfer of embB codon 306 mutations into clinical Mycobacterium tuberculosis strains alters susceptibility to ethambutol, isoniazid, and rifampin.Drug-susceptibility testing in TB: current status and future prospects.Importance of specimen pretreatment for the low-level detection of mycobacterial lipoarabinomannan in human serum.The role of the embA and embB gene products in the biosynthesis of the terminal hexaarabinofuranosyl motif of Mycobacterium smegmatis arabinogalactan.Novel approaches to the inhibition of cytokine responses in asthma.[Resistant tuberculosis: a molecular review].Roles of conserved proline and glycosyltransferase motifs of EmbC in biosynthesis of lipoarabinomannan.The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism: novel insights into drug mechanisms of action.embCAB sequence variation among ethambutol-resistant Mycobacterium tuberculosis isolates without embB306 mutation
P2860
Q24793787-A03A0C56-265C-487C-9756-4D8AC6441745Q28260573-8D8DC46D-7347-44F6-8693-E94F3454BB8EQ28343859-F6028503-D961-4C16-8E00-EBB99FCD2436Q28486772-73E0906D-9AEF-4A1F-B374-054E69A2FF06Q28487222-87F64706-E3BB-434F-9472-23A3698934CFQ31552260-A8D0AB18-9471-4746-9024-C1C2023D4EC8Q33243649-A2204406-E300-4815-A579-83B07C662DE9Q33266918-80A5FCCF-6EAB-433E-A452-8978269B802BQ33289714-76DECD40-D457-48E1-BFB0-DE2BEF2B6EA8Q33630442-137F4AF2-6535-49C7-9018-CE4E529BD5E2Q33809876-75474E85-E149-4996-9D7C-E53EA74719C9Q33935393-0E3EB0A9-BC56-49C8-9427-DB3CFBB092D8Q34568947-57639344-C1F8-42E5-A4E4-6CA2F5256FB5Q34570395-BB633828-AAF2-42E7-A3A3-50D6FFB641B5Q36125186-735CE189-4C22-4273-8995-20BC02C90314Q37038925-F5697C2F-F94F-4833-A693-F877407A0106Q37598711-ECCDC3A3-FF58-4C94-9BBF-F141FF84C97CQ38782638-15F2AE9B-779F-4DBF-A6FE-5CC2C6E1E6E9Q38898564-78D7322A-9A06-4644-B68B-351547A40F12Q39872573-22D60523-30CC-4ED0-947E-7A8098A39E01Q40416538-699DAA39-6C14-4F0E-8FC2-80233C6BD929Q40679743-8D8130B5-B867-4630-A572-54DEDA562325Q41493384-E58A87F4-87A8-4108-BD03-BFE44EDEAC19Q44168515-33496B05-2360-4D2B-A8E6-F476AD9F03C7Q45152585-6A3DE09F-1BF4-49C2-B125-C03093E57E43Q47215316-83B26F2D-4B55-40CA-B99D-F791570D3086Q58485197-09E13A52-07D7-482D-91BA-C6E0C0770C88
P2860
Truncated structural variants of lipoarabinomannan in ethambutol drug-resistant strains of Mycobacterium smegmatis. Inhibition of arabinan biosynthesis by ethambutol.
description
1996 nî lūn-bûn
@nan
1996年の論文
@ja
1996年論文
@yue
1996年論文
@zh-hant
1996年論文
@zh-hk
1996年論文
@zh-mo
1996年論文
@zh-tw
1996年论文
@wuu
1996年论文
@zh
1996年论文
@zh-cn
name
Truncated structural variants ...... an biosynthesis by ethambutol.
@en
type
label
Truncated structural variants ...... an biosynthesis by ethambutol.
@en
prefLabel
Truncated structural variants ...... an biosynthesis by ethambutol.
@en
P2093
P2860
P356
P1476
Truncated structural variants ...... an biosynthesis by ethambutol.
@en
P2093
Brennan PJ
Chatterjee D
Inamine JM
Mikusová K
P2860
P304
28682-28690
P356
10.1074/JBC.271.45.28682
P407
P577
1996-11-01T00:00:00Z